Form 4: Arcellx Director, Kavita Patel, Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Arcellx director Kavita Patel exercised stock options and sold shares on December 24, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On December 24, 2024, Arcellx director Kavita Patel exercised stock options to acquire 1,500 shares of common stock at a price of $6.66 per share.
- Concurrently, Ms. Patel sold 1,500 shares of common stock, with 1,400 shares sold at a weighted average price of $76.9211 and 100 shares sold at $77.61.
- The sales were executed under a Rule 10b5-1 trading plan established on March 28, 2024.
- Following these transactions, Ms. Patel's direct holdings of Arcellx common stock were reduced to zero.
- Ms. Patel also holds 39,077 stock options.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing detailing stock transactions by a company director. It does not contain any information that would be considered positive or negative for the company's outlook.
Industry Context
This is a routine filing related to insider trading activity, which is common for publicly traded companies. The use of a 10b5-1 plan indicates a pre-planned approach to stock sales.
Comparison to Industry Standards
- The use of a 10b5-1 trading plan is a common practice among corporate insiders to avoid accusations of trading on non-public information, aligning with industry standards.
- The reported transactions are typical for directors and officers of publicly traded companies who often receive stock options as part of their compensation.
- The price range of the stock sales is consistent with the market price of Arcellx stock at the time of the transaction.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they are part of a pre-planned trading strategy.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2021-12-01 | Vesting Commencement Date for stock options. |
| 2024-03-28 | Date the Rule 10b5-1 trading plan was established. |
| 2024-12-13 | Date of execution of the Power of Attorney. |
| 2024-12-24 | Date of stock option exercise and stock sales. |
| 2024-12-26 | Date of filing of the Form 4. |
Keywords
Arcellx, stock options, insider trading, Form 4, Rule 10b5-1, Kavita Patel, stock sale, equity securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.